非典型的慢性炎症性脱髓化多基基隆性神经病症与眼和抗硫酸胺IgM阳性

相关实验视频

Updated: Jul 14, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.5K

Li Chen1, Yanjun Zhang2, Nan Qin1

  • 1Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.

The Journal of international medical research
|October 9, 2023
PubMed
概括

这项案例研究突出了一个患有慢性炎症性脱叶林性多基隆性神经病症 (CIDP) 的患者,呈现出眼和抗硫化物IgM抗体. 用IVIg和葡萄糖皮质体治疗显示部分症状有所改善.

关键词:
慢性炎症性去髓化的多基基隆隆性神经病变.抗硫酸胺抗体的抗体案例报告案例报告头骨神经神经的部位眼科医生 眼科医生 眼科医生周围神经系统 周围神经系统

更多相关视频

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.3K
Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay05:45

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

23.4K

相关概念视频

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
937
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K